Although healthcare stocks aren’t known for their dividend prowess, the biopharma sector has the ability to produce higher payouts as a way to encourage investors. However, finding picks with the right blend of risk and reward is often challenging in this R&D-intensive segment of the healthcare industry. Our latest addition to the Best Healthcare Dividend Stocks List is a leading biopharmaceutical company with a large portfolio of prescription treatments.
Thanks to a combination of strong domestic and international sales, a growing portfolio of promising drug pipelines and reaffirmed guidance from management, our biopharma pick offers a strong value proposition. Our pick – and its predecessor’s 50-year track record of higher dividend payments – should give income investors peace of mind when adding this selection to their portfolio.
To make room for our biopharma pick, we’ve booked profits and sold off our holdings of an established pharmaceutical company.
You can check out the Best Healthcare Dividend Stocks List to explore all the stocks.
